GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » CVS Health Corp (NYSE:CVS) » Definitions » Beta

CVS Health (CVS Health) Beta : 0.40 (As of Apr. 26, 2024)


View and export this data going back to 1952. Start your Free Trial

What is CVS Health Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2024-04-26), CVS Health's Beta is 0.40.


CVS Health Beta Historical Data

The historical data trend for CVS Health's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CVS Health Beta Chart

CVS Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.10 0.86 0.61 0.59 0.41

CVS Health Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.59 0.56 0.56 0.58 0.41

Competitive Comparison of CVS Health's Beta

For the Healthcare Plans subindustry, CVS Health's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CVS Health's Beta Distribution in the Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, CVS Health's Beta distribution charts can be found below:

* The bar in red indicates where CVS Health's Beta falls into.



CVS Health Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.


CVS Health  (NYSE:CVS) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


CVS Health Beta Related Terms

Thank you for viewing the detailed overview of CVS Health's Beta provided by GuruFocus.com. Please click on the following links to see related term pages.


CVS Health (CVS Health) Business Description

Address
One CVS Drive, Woonsocket, RI, USA, 02895
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the U.S. CVS is also the largest pharmacy benefit manager (acquired through Caremark), processing over 2 billion adjusted claims annually. It also operates a top-tier health insurer (acquired through Aetna) where it serves about 26 million medical members. The company's recent acquisition of Oak Street adds primary care services to the mix, which could have significant synergies with all its existing business lines.
Executives
Edward J Ludwig director C/O BECTON DICKERSON & CO, 1 BECTON DR, FRANKLIN LAKES NJ 07417
Michael F Mahoney director BOSTON SCIENTIFIC CORPORATION, 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH MA 01752-1234
Thomas F. Cowhey officer: SVP, Interim CFO 310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
J Scott Kirby director 233 S. WACKER DRIVE 11TH FL WHQLD, CHICAGO IL 60606
Brian A Kane officer: EVP/President, Aetna 500 W MAIN STREET, LOUISVILLE KY 40202
James David Clark officer: SVP, Cont & Chief Acct Officer ONE CVS DRIVE, WOONSOCKET RI 02760
Karen S Lynch officer: EVP & Pres, Aetna Bus Unit 151 FARMINGTON AVENUE, RW61, HARTFORD CT 06156
Samrat S. Khichi officer: EVP, CPO and General Counsel C/O CATALENT, INC., 14 SCHOOLHOUSE ROAD, SOMERSET NJ 08873
Thomas M Moriarty officer: EVP & General Counsel 100 PARSONS POND DRIVE, FRANKLIN LAKES NJ 07417
Jeffrey R. Balser director 3657 RICHLAND AVE., NASHVILLE TN 37205
Alan Lotvin officer: EVP, Transformation 55 NOD ROAD, AVON CT 06001
Daniel P Finke officer: EVP/Pres, Health Care Benefits ONE CVS DRIVE, WOONSOCKET RI 02895
Tilak Mandadi officer: EVP, Chief Technology Officer 3600 LAS VEGAS BLVD. SOUTH, LAS VEGAS NV 89109
Sreekanth K Chaguturu officer: EVP and Chief Medical Officer ONE CVS DRIVE, WOONSOCKET RI 02895
Prem S Shah officer: EVP and Co-President of Retail ONE CVS DRIVE, WOONSOCKET RI 02895

CVS Health (CVS Health) Headlines

From GuruFocus

Q3 2023 CVS Health Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q4 2021 CVS Health Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q1 2022 CVS Health Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q2 2022 CVS Health Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q2 2023 CVS Health Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024

CVS Health Corp Annual Shareholders Meeting Transcript

By GuruFocus Research 01-22-2024